Targetech Innovation Center portfolio company Nervomatrix Ltd. , which has developed an auto-targeting neurostimulation device for lower back pain relief, has obtained US Food and Drug Administration (FDA) approval to market the device in the US. The …
More here:
Nervomatrix back pain device wins FDA nod – Globes – Israel Business Arena
